All Type of News
JW Pharmaceutical, Kazakh firm sign MOU for amino acid infusions plant
JW Pharmaceutical Corp. Friday signed a memorandum of understanding (MOU) with Kazakhstan's largest pharmaceutical firm JSC Chempharm for a feasibility study on building an amino acid solutions plant.
Together with...
Ildong forges strategic tie-up with Sandoz Korea
Ildong Pharmaceutical Co. says it has established a marketing and distribution partnership with Sandoz Korea.
Under the deal, Ildong will be in charge of selling Sandoz drugs using its extensive domestic distributi...
KFDA urged to ensure safety of OTC medicines
The use of many popular over-the-counter (OTC) cold remedies and pain relievers carries the risks of side effects, and from now on, the Korea Food and Drug Administration has to strictly control these drugs.
In a l...
NHIC urged to clim illegal selling of generic drugs with bioequivalence data fabrication
For more than three years since 2008, the National Health Insurance Corp. has staged an uphill battle with 93 pharmaceutical firms that submitted falsified bioequivalence data on 231 medicines.
In each lawsuit, the...
Buflomedil products to be pulled from shelves
A total of 31 buflomedil-containing medicinal products, including Whanin Pharmaceutical’s Pirxane tablets, will face being banned in the Korean market as the Korea Food and Drug Administration (KFDA) on Thursday order...
Green Cross holds symposium for new botanical drug for osteoporosis
Green Cross Corp. said Wednesday that it held a launching symposium for its new botanical drug for osteoporosis treatment, Sinbaro capsule.
About 200 doctors from various departments of orthopedic, rheumatic intern...
Levitra ODT gaining popularity
A growing number of customers here are turning their eyes to Bayer Healthcare’s new dissolvable erectile dysfunction tablet called Levitra ODT (Orodispersible).
With a catchphrase titled ‘Good-Bye Water,’ Levitra O...
Is Pfizer neglecting recall of defected Caverject injection?
Pharmaceutical giant Pfizer is accused of its failure in recalling about 81 lots of anti-impotence shot Caverject because of the potential for defective needles, inviting criticism from domestic pharmacists.
The ac...
Pharmaceutical firms reluctant to spend on R&D
A total of 30 pharmaceutical companies that chalked up the combined sales of over 3.8 trillion won for the first half of this year, invested 240.3 billion won in research, an average 6.3 percent of their revenue.
Y...
Drug makers’ first-half promotional expenses declined
Two out of five Korean pharmaceutical firms slashed their promotional expenses by more than 30 percent in the first half of this year due to the government’s policy to abandon “rebates” ― a kind of kickback given by d...
